Biotechnology Collaboration Deals and Laboratory Market Reports Released for 2026

Three comprehensive market research reports covering biotechnology collaboration agreements and analytical laboratory technologies were released in March 2026, providing detailed analysis of industry trends and growth projections through 2035.

The Collaboration Deals in Biotechnology report was added to ResearchAndMarkets.com's offering on March 12, 2026. The report provides a comprehensive analysis of collaboration partnerships across the biotechnology sector and includes 2,096 collaboration deals announced between 2020 and 2026. Each deal record includes financial information where available and links to online deal records and contract documents filed with regulators when publicly disclosed. The report is designed for business development, licensing, legal, and strategy professionals, delivering detailed insight into how biotech companies structure collaborative alliances, negotiate financial terms, and share development and commercialization responsibilities.

The report provides analysis of collaboration dealmaking trends since 2020, overview of collaboration partnership structures and financial models, review of leading collaboration deals by disclosed value, and profiles of the most active collaboration dealmakers. It includes detailed analysis of deals by company, therapeutic area, and technology type, along with a comprehensive deal directory covering all collaboration agreements announced since 2020.

Where available, the report provides access to actual collaboration agreements filed with the SEC, offering insight into rights granted or optioned, financial payment structures and milestone triggers, intellectual property ownership and licensing rights, development and commercialization responsibilities, exclusivity provisions and partnership governance, and deal duration and termination clauses.

The Global Gas Chromatography Market Size is valued at USD 3.34 Bn in 2025 and is predicted to reach USD 6.30 Bn by the year 2035 at a 6.8% CAGR during the forecast period for 2026 to 2035. The market analysis covers distribution by product type including instruments (systems, detectors, auto-samplers, fraction collectors) and accessories and consumables (fittings and tubing, gas generators, flow management and pressure regulator accessories, columns, reagents and solvents, auto-sampler accessories, column accessories, others). Applications analyzed include drug development and quality control, bioprocess monitoring, clinical and medical diagnostics, and others. End-users examined include pharmaceutical and biotechnology companies, clinical laboratories, and academic and research institutes.

Gas chromatography remains one of the most widely applied separation techniques in analytical chemistry, enabling the high-resolution separation, identification, and quantification of volatile and semi-volatile compounds in complex matrices. The method relies on the differential partitioning of analytes between a mobile phase (inert carrier gas) and a stationary phase within a temperature-controlled column, followed by detection using sensitive detectors such as flame ionization (FID), mass spectrometry (MS), or thermal conductivity (TCD).

Recent instrumental and methodological advances particularly in capillary column technology, multidimensional GC (GC×GC), and hyphenated techniques such as GC-MS/MS have further expanded its analytical power and applicability. Instrument innovations such as compact and portable GC systems have broadened the range of gas chromatography applications. Advancements in detector technology, column efficiency, and data analysis software improve the accuracy and dependability of results.

The biotechnology and pharmaceutical sectors are undergoing fast change, characterized by rigorous quality control procedures, strong regulatory compliance, and notable advances in medication research. Gas chromatography has become a key technology that is essential to ensuring the stability, potency, and purity of medicinal substances, making it possible to precisely and accurately separate, identify, and quantify chemical components.

The Global Western Blotting Market size is expected to be worth around US$ 4.3 Billion by 2035 from US$ 2.4 Billion in 2025, growing at a CAGR of 6.1% during the forecast period 2026-2035. In 2025, North America led the market, achieving over 42.4% share with a revenue of US$ 1.0 Billion. The market is analyzed by product type (reagent kits, electrophoresis blotting systems and transfer membranes), by application (scientific research, medical diagnostics, food and beverages, agricultural application and others), and by end user (pharmaceutical and biotechnology companies, diagnostic laboratories and research institutions).

Growing demand for precise protein detection and quantification in life sciences research propels the Western blotting market as laboratories require reliable methods to validate protein expression, post-translational modifications, and molecular interactions. Researchers increasingly apply Western blotting in cancer biology to confirm oncoprotein levels and phosphorylation states in cell lines treated with targeted inhibitors, guiding mechanistic studies and drug efficacy assessments.

Neuroscientists utilize Western blotting to quantify neurodegenerative markers such as tau and amyloid-beta aggregates in brain tissue lysates, advancing understanding of Alzheimer's and Parkinson's pathology. Virologists employ the method to verify viral protein expression and host response factors during infection studies, facilitating antiviral compound screening. Pharmaceutical developers rely on Western blotting for quality control of recombinant proteins, ensuring correct molecular weight and purity in biologics manufacturing pipelines.

Reagent kits contributed 47.6% of growth within product type and led the western blotting market due to their recurring consumption and essential role in protein detection workflows. Laboratories depend on antibodies, buffers, substrates, and detection reagents for every blotting experiment, which creates continuous demand. Scientific research held a significant share of 52.4% among applications, while the pharmaceutical and biotechnology companies sector stands out as the dominant player, holding the largest revenue share of 44.8% in the market among end users.

Manufacturers pursue opportunities to develop automated Western blotting systems that streamline gel electrophoresis, transfer, and detection steps, expanding applications in high-throughput screening for biomarker validation and antibody specificity testing. Developers advance chemiluminescent and fluorescent detection reagents with enhanced sensitivity, broadening utility in low-abundance protein analysis across proteomics workflows. Recent trends emphasize integration with mass spectrometry for orthogonal validation and AI-assisted band quantification, positioning Western blotting as an indispensable tool in translational research and biopharmaceutical development.